Pneumonia
Conditions
Brief summary
To identifying biomarkers in patients with pneumonia
Detailed description
The aim of this study is to identify the biomarkers in patients with pneumonia. These biomarkers can distinguish community-acquired pneumonia, hospital-acquired pneumonia, severe pneumonia, bacterial infection, virus infection and fungal infection. Furthermore, these biomarkers can identify the efficacy of treatment in patients with different interventions.
Interventions
None listed
Sponsors
Chongqing Medical University
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Healthy patients without any diseases -
Exclusion criteria
Age less than 18 years \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| mortality | From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first | Mortality is defined the patient died in hospital. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| severe pneumonia | From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first | The pneumonia deteriorated and reached the criteria of severe pneumonia. Severe pneumonia was diagnosed according to the guideline published by ATS. |
| initial treatment failure | From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first | Initial treatment failure means the patients' condition progressively deteriorated although comprehensive treatment was administrated. As a result, the treatment should be changed or the patient required admission to ICU. |
Countries
China
Contacts
PRINCIPAL_INVESTIGATORJun Duan, MD
First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed